Sowell Financial Services’s Kindred Biosciences, Inc. KIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,231
Closed -$10K 3405
2020
Q4
$10K Buy
2,231
+53
+2% +$216 ﹤0.01% 2039
2020
Q3
$9K Buy
2,178
+337
+18% +$1.41K ﹤0.01% 1849
2020
Q2
$8K Buy
1,841
+125
+7% +$559 ﹤0.01% 1787
2020
Q1
$7K Buy
1,716
+659
+62% +$5.6K ﹤0.01% 1748
2019
Q4
$9K Hold
1,057
﹤0.01% 1739
2019
Q3
$7K Buy
+1,057
New +$7.75K ﹤0.01% 1668

Other funds holding KIN

Sowell Financial Services's KIN Position: Q1 2021 in Review

Sowell Financial Services sold out of Kindred Biosciences, Inc. (KIN) in Q1 2021, closing a stake of 2,231 shares — an estimated $10K sold.

Sowell Financial Services first reported a position in KIN in Q3 2019 and held it in 6 quarters. The position peaked at $10K in Q4 2020. 84 funds tracked by Wall St. Rank hold KIN as of Q1 2021.

  • Sowell Financial Services reported no remaining Kindred Biosciences, Inc. position as of Q1 2021 after selling out during the quarter.
  • Sowell Financial Services sold 2,231 Kindred Biosciences, Inc. shares in Q1 2021, an estimated $10K.
  • Sowell Financial Services first reported a position in Kindred Biosciences, Inc. in Q3 2019 and held it in 6 quarters.
  • Sowell Financial Services's Kindred Biosciences, Inc. position peaked at $10K in Q4 2020.
  • 84 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q1 2021.

Based on Sowell Financial Services's 13F filing for Q1 2021, filed 7 May 2021.